Expert Opinion on Pharmacotherapy logo Informa Healthcare logo

Publisher: Informa Healthcare

Volume 5, Number 6, 1 June 2004
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

< previous issue | next issue > | all issues

Review article

Chemotherapeutic management of malignant pleural effusion
pp. 1233-1242(10)
Authors: Weatherhead M.; Antunes G.

Delaying surgery with chemotherapy for osteosarcoma of the extremities
pp. 1243-1256(14)
Authors: Bielack S.S.; Machatschek J-N.; Flege S.; Jürgens H.

Pharmacological management of Ewing sarcoma family of tumours
pp. 1257-1270(14)
Author: Rodriguez-Galindo C.

Gallbladder cancer: current status
pp. 1271-1277(7)
Author: Malik I.A.

The role of alpha-blockers in the management of prostate cancer
pp. 1279-1285(7)
Authors: Tahmatzopoulos A.; Rowland R.G.; Kyprianou N.

Management of pituitary apoplexy
pp. 1287-1298(12)
Authors: Chanson P.; Lepeintre J-F.; Ducreux D.

Pharmacological strategies in relieving neuropathic pain
pp. 1299-1312(14)
Author: McCleane G.

Pharmacological management of attention-deficit hyperactivity disorder
pp. 1313-1320(8)
Authors: Reeves G.; Schweitzer J.

Drug Evaluation

A review of the proteasome inhibitor bortezomib in multiple myeloma
pp. 1321-1331(11)
Author: Richardson P.G.

Review of the immunosuppressant enteric-coated mycophenolate sodium
pp. 1333-1345(13)
Authors: Budde K.; Glander P.; Diekmann F.; Waiser J.; Fritsche L.; Dragun D.; Neumayer H-H.

Aceclofenac in the management of inflammatory pain
pp. 1347-1357(11)
Author: Legrand E.

Long-term oral carvedilol in chronic heart failure
pp. 1359-1372(14)
Authors: Di Lenarda A.; Sabbadini G.; Moretti M.; Sinagra G.

Fondaparinux: a Factor Xa inhibitor for antithrombotic therapy
pp. 1373-1384(12)
Author: Turpie A.G.

Extended-release niacin for modifying the lipoprotein profile
pp. 1385-1398(14)
Author: Guyton J.R.

Rivastigmine in vascular dementia
pp. 1399-1410(12)
Authors: Moretti R.; Torre P.; Antonello R.M.; Cazzato G.; Bava A.

Rosiglitazone plus metformin: combination therapy for Type 2 diabetes
pp. 1411-1422(12)
Authors: Del Prato S.; Volpe L.

Miscellaneous

The therapeutic potential of ximelagatran to become the anticoagulant of choice in medicine: a review of recently completed clinical trials
pp. 1423-1430(8)
Authors: Salam A.M.; Al-Mousa E.N.

Sirolimus- versus paclitaxel-eluting stents in patients with stenosis in a native coronary artery
pp. 1431-1434(4)
Author: Doggrell S.A.

< previous issue | next issue > | all issues

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A